What is a suitable taper schedule for a 54-year-old female patient taking tramadol (tramadol hydrochloride) extended release 100mg twice a day (BID) who wants to undergo a slow taper of 10-15%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tramadol Extended Release Tapering Schedule for a 54-Year-Old Female

A slow taper of tramadol extended release at 10-15% reduction every 2 weeks is recommended for this patient, with careful monitoring for withdrawal symptoms and adjustment of the taper rate as needed.

Current Medication Status

  • 54-year-old female
  • Currently on tramadol extended release 100mg BID (200mg daily total)
  • Desires a slow taper at 10-15% reduction rate

Tapering Rationale and Approach

The CDC Clinical Practice Guideline (2022) recommends that when tapering opioids:

  • Tapers should be slow enough to minimize withdrawal symptoms
  • For patients on long-term opioid therapy, tapers of 10% per month or slower are better tolerated 1
  • Patient collaboration in the tapering plan is essential for success
  • The taper may need to be paused or slowed as patients reach lower dosages

Recommended Tapering Schedule

Phase 1: Initial Reduction (Weeks 1-2)

  • Continue tramadol ER 100mg in morning
  • Reduce evening dose to 75mg
  • Total daily dose: 175mg (12.5% reduction)

Phase 2: Second Reduction (Weeks 3-4)

  • Continue tramadol ER 100mg in morning
  • Reduce evening dose to 50mg
  • Total daily dose: 150mg (25% total reduction)

Phase 3: Third Reduction (Weeks 5-6)

  • Reduce morning dose to 75mg
  • Continue evening dose at 50mg
  • Total daily dose: 125mg (37.5% total reduction)

Phase 4: Fourth Reduction (Weeks 7-8)

  • Continue morning dose at 75mg
  • Reduce evening dose to 25mg
  • Total daily dose: 100mg (50% total reduction)

Phase 5: Fifth Reduction (Weeks 9-10)

  • Reduce morning dose to 50mg
  • Continue evening dose at 25mg
  • Total daily dose: 75mg (62.5% total reduction)

Phase 6: Sixth Reduction (Weeks 11-12)

  • Continue morning dose at 50mg
  • Discontinue evening dose
  • Total daily dose: 50mg (75% total reduction)

Phase 7: Final Reduction (Weeks 13-14)

  • Reduce morning dose to 25mg
  • Total daily dose: 25mg (87.5% total reduction)

Phase 8: Discontinuation (Weeks 15-16)

  • Take 25mg every other day for 1 week
  • Then discontinue completely

Important Considerations

Compounding Options

  • For intermediate doses not commercially available (75mg, 25mg), request compounded capsules from a pharmacy
  • Alternatively, use commercially available 50mg tablets that can be split for the 25mg dose

Monitoring During Taper

  • Follow up at least monthly during the taper 1
  • Monitor for withdrawal symptoms: anxiety, insomnia, abdominal pain, vomiting, diarrhea, diaphoresis, tremor 1
  • If withdrawal symptoms become significant, pause the taper and maintain the current dose for an additional 2-4 weeks before resuming

Adjustments to Schedule

  • The taper may need to be slowed further as the patient reaches lower doses
  • Consider extending each phase to 3-4 weeks if the patient experiences difficulty
  • The taper may be paused temporarily if needed, especially when reaching doses below 50mg daily

Special Considerations

  • For patients over 65 years old, dose selection should be cautious, starting at the low end of the dosing range 2
  • For patients with renal impairment (CrCl <30 mL/min), the maximum daily dose should not exceed 200mg 2
  • For patients with hepatic impairment, the recommended dose is 50mg every 12 hours 2

Non-Pharmacological Support During Taper

  • Maximize non-opioid pain management strategies
  • Consider referral to physical therapy if appropriate
  • Provide education about expected withdrawal symptoms and their management
  • Consider psychological support during the tapering process

By following this gradual tapering schedule of approximately 10-15% reduction every 2 weeks, the patient should be able to discontinue tramadol extended release with minimal withdrawal symptoms over a 3-4 month period.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.